These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30701774)

  • 1. The cardiovascular system in patients with functional and inflammatory bowel diseases.
    Maev IV; Kazulin AN; Andreev DN
    Ter Arkh; 2018 Feb; 90(2):59-64. PubMed ID: 30701774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients with longstanding ulcerative colitis in remission do not have more irritable bowel syndrome-like symptoms than controls.
    Lundgren D; Rutegård J; Eklöf V; Palmqvist R; Karling P
    BMC Gastroenterol; 2016 Nov; 16(1):139. PubMed ID: 27881072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of 5-hydroxytryptophan signaling pathway characteristics in diarrhea-predominant irritable bowel syndrome and ulcerative colitis.
    Yu FY; Huang SG; Zhang HY; Ye H; Chi HG; Zou Y; Lv RX; Zheng XB
    World J Gastroenterol; 2016 Mar; 22(12):3451-9. PubMed ID: 27022227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive dysfunction in ulcerative colitis patients in remission and its comparison with patients with irritable bowel syndrome and healthy controls.
    Sharma N; Dhiman S; Bodh V; Sharma D; Sharma R; Sharma S; Sharma B
    Indian J Gastroenterol; 2021 Apr; 40(2):169-175. PubMed ID: 33417176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of functional dyspepsia-like symptoms in ulcerative colitis patients in clinical remission and overlap with irritable bowel syndrome-like symptoms.
    Kotani S; Fukuba N; Kawashima K; Mishima Y; Sonoyama H; Okimoto E; Tada Y; Oka A; Tamagawa Y; Oshima N; Mishiro T; Tobita H; Shibagaki K; Moriyama I; Ishimura N; Kushiyama Y; Fujishiro H; Ishihara S
    Scand J Gastroenterol; 2020 May; 55(5):560-564. PubMed ID: 32412797
    [No Abstract]   [Full Text] [Related]  

  • 6. The central role of psychopathology and its association with disease severity in inflammatory bowel disease and irritable bowel syndrome.
    Piacentino D; Cesarini M; Badiali D; Pallotta N; Biondi M; Corazziari ES
    Riv Psichiatr; 2019; 54(2):75-83. PubMed ID: 30985832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis.
    Halpin SJ; Ford AC
    Am J Gastroenterol; 2012 Oct; 107(10):1474-82. PubMed ID: 22929759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of irritable bowel syndrome-like symptoms in ulcerative colitis patients with clinical and endoscopic evidence of remission: prospective multicenter study.
    Fukuba N; Ishihara S; Tada Y; Oshima N; Moriyama I; Yuki T; Kawashima K; Kushiyama Y; Fujishiro H; Kinoshita Y
    Scand J Gastroenterol; 2014 Jun; 49(6):674-80. PubMed ID: 24646420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative characteristics of fatigue in irritable bowel syndrome and inflammatory bowel disease: A systematic review and meta-analysis.
    Kim YJ; Lee SG; Lee JS; Choi YJ; Son CG
    J Psychosom Res; 2024 Feb; 177():111589. PubMed ID: 38199049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leaky gut in patients with diarrhea-predominant irritable bowel syndrome and inactive ulcerative colitis.
    Gecse K; Róka R; Séra T; Rosztóczy A; Annaházi A; Izbéki F; Nagy F; Molnár T; Szepes Z; Pávics L; Bueno L; Wittmann T
    Digestion; 2012; 85(1):40-6. PubMed ID: 22179430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of geographic distributions of Irritable Bowel Syndrome with Inflammatory Bowel Disease fail to support common evolutionary roots: Irritable Bowel Syndrome and Inflammatory Bowel Diseases are not related by evolution.
    Szilagyi A; Xue X
    Med Hypotheses; 2018 Jan; 110():31-37. PubMed ID: 29317064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The severity of inflammation at onset of ulcerative colitis is not associated with IBS-like symptoms during clinical remission.
    Jonefjäll B; Simrén M; Öhman L; Lasson A; Svedlund J; Strid H
    J Crohns Colitis; 2015 Sep; 9(9):776-83. PubMed ID: 26079726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ulcerative colitis and irritable bowel syndrome: relationships with quality of life.
    Ansari R; Attari F; Razjouyan H; Etemadi A; Amjadi H; Merat S; Malekzadeh R
    Eur J Gastroenterol Hepatol; 2008 Jan; 20(1):46-50. PubMed ID: 18090990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abdominal pain in patients with inflammatory bowel disease: association with single-nucleotide polymorphisms prevalent in irritable bowel syndrome and clinical management.
    Ledergerber M; Lang BM; Heinrich H; Biedermann L; Begré S; Zeitz J; Krupka N; Rickenbacher A; Turina M; Greuter T; Schreiner P; Roth R; Siebenhüner A; Vavricka SR; Rogler G; Beerenwinkel N; Misselwitz B;
    BMC Gastroenterol; 2021 Feb; 21(1):53. PubMed ID: 33546600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation exposure in patients with inflammatory bowel disease and irritable bowel syndrome in the years 2001-2011.
    Englund H; Lidén K K; Lind T; Sundström T; Karling P
    Scand J Gastroenterol; 2017 Mar; 52(3):300-305. PubMed ID: 27832710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
    Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B
    World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation.
    Vivinus-Nébot M; Frin-Mathy G; Bzioueche H; Dainese R; Bernard G; Anty R; Filippi J; Saint-Paul MC; Tulic MK; Verhasselt V; Hébuterne X; Piche T
    Gut; 2014 May; 63(5):744-52. PubMed ID: 23878165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic Inflammatory Protein Profiles Distinguish Irritable Bowel Syndrome (IBS) and Ulcerative Colitis, Irrespective of Inflammation or IBS-Like Symptoms.
    Moraes L; Magnusson MK; Mavroudis G; Polster A; Jonefjäll B; Törnblom H; Sundin J; Simrén M; Strid H; Öhman L
    Inflamm Bowel Dis; 2020 May; 26(6):874-884. PubMed ID: 31901089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and Impact of Inflammatory Bowel Disease-Irritable Bowel Syndrome on Patient-reported Outcomes in CCFA Partners.
    Abdalla MI; Sandler RS; Kappelman MD; Martin CF; Chen W; Anton K; Long MD
    Inflamm Bowel Dis; 2017 Feb; 23(2):325-331. PubMed ID: 28092305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.